CAR-T cell therapy for lung cancer: a promising but challenging future

被引:40
作者
Zhong, Shupeng [1 ]
Cui, Yingqiang [1 ]
Liu, Qian [2 ]
Chen, Size [1 ]
机构
[1] Guangdong Pharmaceut Univ, Guangdong Prov Engn Res Ctr Esophageal Canc Preci, Affiliated Hosp 1, Dept Oncol, Guangzhou 510080, Peoples R China
[2] Guangdong Pharmaceut Univ, Guangdong Prov Engn Res Ctr Esophageal Canc Preci, Affiliated Hosp 1, Cent Lab, Guangzhou 510080, Peoples R China
关键词
CARCINOEMBRYONIC ANTIGEN; IMMUNOTHERAPY; EXPRESSION;
D O I
10.21037/jtd.2020.03.118
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
[No abstract available]
引用
收藏
页码:4516 / 4521
页数:6
相关论文
共 25 条
[1]   Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity [J].
Adusumilli, Prasad S. ;
Cherkassky, Leonid ;
Villena-Vargas, Jonathan ;
Colovos, Christos ;
Servais, Elliot ;
Plotkin, Jason ;
Jones, David R. ;
Sadelain, Michel .
SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (261)
[2]   Carcinoembryonic antigen as a target for therapeutic anticancer vaccines: A review [J].
Berinstein, NL .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (08) :2197-2207
[3]   Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains [J].
Carpenito, Carmine ;
Milone, Michael C. ;
Hassan, Raffit ;
Simonet, Jacqueline C. ;
Lakhal, Mehdi ;
Suhoski, Megan M. ;
Varela-Rohena, Angel ;
Haines, Kathleen M. ;
Heitjan, Daniel F. ;
Albelda, Steven M. ;
Carroll, Richard G. ;
Riley, James L. ;
Pastan, Ira ;
June, Carl H. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (09) :3360-3365
[4]   Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes [J].
Caruana, Ignazio ;
Savoldo, Barbara ;
Hoyos, Valentina ;
Weber, Gerrit ;
Liu, Hao ;
Kim, Eugene S. ;
Ittmann, Michael M. ;
Marchetti, Dario ;
Dotti, Gianpietro .
NATURE MEDICINE, 2015, 21 (05) :524-U158
[5]   NR4A transcription factors limit CAR T cell function in solid tumours [J].
Chen, Joyce ;
Lopez-Moyado, Isaac F. ;
Seo, Hyungseok ;
Lio, Chan-Wang J. ;
Hempleman, Laura J. ;
Sekiya, Takashi ;
Yoshimura, Akihiko ;
Scott-Browne, James P. ;
Rao, Anjana .
NATURE, 2019, 567 (7749) :530-+
[6]  
Chen S, 2018, ANN ONCOL, V29
[7]   Profiling cancer testis antigens in non-small-cell lung cancer [J].
Djureinovic, Dijana ;
Hallstrom, Bjorn M. ;
Horie, Masafumi ;
Mattsson, Johanna Sofia Margareta ;
La Fleur, Linnea ;
Fagerberg, Linn ;
Brunnstrom, Hans ;
Lindskog, Cecilia ;
Madjar, Katrin ;
Rahnenfuehrer, Joerg ;
Ekman, Simon ;
Stahle, Elisabeth ;
Koyi, Hirsh ;
Branden, Eva ;
Edlund, Karolina ;
Hengstler, Jan G. ;
Lambe, Mats ;
Saito, Akira ;
Botling, Johan ;
Ponten, Fredrik ;
Uhlen, Mathias ;
Micke, Patrick .
JCI INSIGHT, 2016, 1 (10)
[8]   CTLA-4: new insights into its biological function and use in tumor immunotherapy [J].
Egen, JG ;
Kuhns, MS ;
Allison, JP .
NATURE IMMUNOLOGY, 2002, 3 (07) :611-618
[9]   Chimeric antigen receptor-modified T cells for the immunotherapy of patients with EGFR-expressing advanced relapsed/refractory non-small cell lung cancer [J].
Feng, Kaichao ;
Guo, Yelei ;
Dai, Hanren ;
Wang, Yao ;
Li, Xiang ;
Jia, Hejin ;
Han, Weidong .
SCIENCE CHINA-LIFE SCIENCES, 2016, 59 (05) :468-479
[10]   T-cell Homing Therapy for Reducing Regulatory T Cells and Preserving Effector T-cell Function in Large Solid Tumors [J].
Hu, Jiemiao ;
Sun, Chuang ;
Bernatchez, Chantale ;
Xia, Xueqing ;
Hwu, Patrick ;
Dotti, Gianpietro ;
Li, Shulin .
CLINICAL CANCER RESEARCH, 2018, 24 (12) :2920-2934